In silico analysis based on constituents of the medicinal plant Xuebijing (XBJ) to identify candidate treatment agents for sepsis in the omics-driven research era

IF 0.9 Q3 Biochemistry, Genetics and Molecular Biology

Minerva Biotecnologica Pub Date : 2021-01-01 DOI:10.23736/S1120-4826.20.02684-1

Zhenyu Xu, Na Yin, R. Ren, Z. Ruan

引用次数: 0

查看原文本刊更多论文

基于药用植物血必净(XBJ)成分的硅片分析，在组学驱动的研究时代确定脓毒症的候选治疗药物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Minerva Biotecnologica 生物-生物工程与应用微生物

CiteScore

2.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Minerva Biotecnologica publishes scientific papers on biotechnology and molecular biology. Manuscripts may be submitted in the form of editorials, original articles, review articles, special articles and letters to the Editor. The journal aims to provide its readers with papers of the highest quality and impact through a process of careful peer review and editorial work.